Medical Xpress on MSN6d
Synthetic microbiome therapy offers new hope against C. difficile infections
A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously ...
The New England Journal of Medicine3d
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of ...
Verywell Health on MSN3d
7 At-Home Treatments to Clear Ringworm Quickly
Most ringworm responds to antifungals you can buy at a pharmacy. This article lists ringworm treatments and includes options ...
Ophthalmology Times3d
FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
The US Food and Drug Administration (FDA) has approved revakinagene taroretcel-lwey (ENCELTO) from Neurotech Pharmaceuticals ...
Science News4d
Treating male partners along with women may help stop bacterial vaginosis
In a clinical trial, treating both partners in a relationship significantly reduced the likelihood of recurrence of bacterial vaginosis.
WebMD5d
FDA Approves New Treatment for Stroke
The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
MyChesCo on MSN4h
FDA Approves Breakthrough Eye Therapy and Expands Life-Saving Allergy Spray for Kids
The U.S. Food and Drug Administration (FDA) has announced significant advancements in medical treatments, including the ...
Rheumatology Advisor2d
Filgotinib Maintains Long-Term Safety and Efficacy in Rheumatoid Arthritis Treatment
Filgotinib maintained a favorable safety and efficacy profile for up to 8 years among patients with RA who participated in the DARWIN 3 LTE.
Medscape4d
Recommendations and Rationale for the Treatment of Pelvic Inflammatory Disease
Treatment of PID should take into account the short-term goals of clinical and microbiological cure and the long-term goals of prevention of infertility, ectopic pregnancy, recurrent infection and ...
Targeted Oncology1d
Exploring Fixed-Duration Ibrutinib and Venetoclax in CLL Treatment
Paolo Ghia, MD, PhD, discusses the CAPTIVATE trial in chronic lymphocytic leukemia/small lymphocytic lymphoma, and what findings from the trial have been particularly noteworthy.